Title of article
Oral allopurinol desensitization
Author/Authors
Kolahi ، Sousan نويسنده , , Tajeddini، Mahdi نويسنده 1Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Tajeddini, Mahdi , Jalilzadeh Binazar، Mehran نويسنده Student Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Jalilzadeh Binazar, Mehran
Issue Information
روزنامه با شماره پیاپی سال 2014
Pages
2
From page
32
To page
33
Abstract
Allopurinol, a xanthine oxidase inhibitor, is an effective urate-lowering drug. Unlike majority of patients tolerate
allopurinol well, in 2% of patients receiving allopurinol, hypersensitivity reactions have been reported. In this case
a 71-year-old woman with tophaceous gout since 10 years ago, presented to our rheumatology clinic. Because of
occurring hypersensitivity reactions, allopurinol was discontinued and disease worsened despite administration of
colchicine. She was admitted several times due to flare up of gout. Other forms of allopurinol are not available
in Iran, so we decided to conduct an allopurinol desensitization protocol with tablets form. Side effects have not
been reported yet.
Journal title
Journal of Case Reports in Practice (JCRP)
Serial Year
2014
Journal title
Journal of Case Reports in Practice (JCRP)
Record number
1026366
Link To Document